Oksana Shlobin, MD, FCCP

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    United Therapeutics
    Topic:
    PH, ILD
    Date added:
    07/13/2023
    Date updated:
    08/25/2025
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Merck
    Topic:
    PH
    Date added:
    09/21/2024
    Date updated:
    08/25/2025
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Gossamer
    Topic:
    PH, ILD
    Date added:
    08/25/2025
    Date updated:
    08/25/2025
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    AllRockBio
    Topic:
    PH, ILD
    Date added:
    08/25/2025
    Date updated:
    08/25/2025
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Insmed
    Topic:
    PH, ILD
    Date added:
    08/25/2025
    Date updated:
    08/25/2025
    Relationship end date:
    12/31/2025
Return to 2025 ISHV Cath, Heart and Lung Conferences: CTEPH